Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?

被引:14
|
作者
Abas, Abdul Hawil [1 ]
Marfuah, Siti [1 ]
Idroes, Rinaldi [2 ]
Kusumawaty, Diah [3 ]
Fatimawali [4 ]
Park, Moon Nyeo [5 ]
Siyadatpanah, Abolghasem [6 ]
Alhumaydhi, Fahad A. [7 ]
Mahmud, Shafi [8 ]
Tallei, Trina Ekawati [1 ]
Bin Emran, Talha [9 ]
Kim, Bonglee [5 ]
机构
[1] Sam Ratulangi Univ, Fac Math & Nat Sci, Dept Biol, Manado 95115, North Sulawesi, Indonesia
[2] Univ Syiah Kuala, Fac Math & Nat Sci, Dept Pharm, Banda Aceh 23111, Aceh, Indonesia
[3] Univ Pendidikan Indonesia, Fac Math & Nat Sci Educ, Dept Biol, Bandung 40154, West Java, Indonesia
[4] Sam Ratulangi Univ, Fac Math & Nat Sci, Pharm Study Program, Manado 95115, North Sulawesi, Indonesia
[5] Kyung Hee Univ, Coll Korean Med, Seoul 05253, South Korea
[6] Birjand Univ Med Sci, Ferdows Sch Paramed & Hlth, Birjand 9717853577, Iran
[7] Qassim Univ, Coll Appl Med Sci, Dept Med Labs, Buraydah 52571, Saudi Arabia
[8] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Sci, Canberra, ACT 0200, Australia
[9] BGC Trust Univ Bangladesh, Dept Pharm, Chittagong 4381, Bangladesh
来源
MOLECULES | 2022年 / 27卷 / 07期
基金
新加坡国家研究基金会;
关键词
COVID-19; SARS-CoV-2; Omicron; natural immunity; hybrid immunity; MAIN PROTEASE; TRANSMISSION; MECHANISMS; INFECTION; VACCINES; FUTURE; ORIGIN;
D O I
10.3390/molecules27072221
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The coronavirus disease 2019 (COVID-19) pandemic is still ongoing, with no signs of abatement in sight. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the causative agent of this pandemic and has claimed over 5 million lives, is still mutating, resulting in numerous variants. One of the newest variants is Omicron, which shows an increase in its transmissibility, but also reportedly reduces hospitalization rates and shows milder symptoms, such as in those who have been vaccinated. As a result, many believe that Omicron provides a natural vaccination, which is the first step toward ending the COVID-19 pandemic. Based on published research and scientific evidence, we review and discuss how the end of this pandemic is predicted to occur as a result of Omicron variants being surpassed in the community. In light of the findings of our research, we believe that it is most likely true that the Omicron variant is a natural way of vaccinating the masses and slowing the spread of this deadly pandemic. While the mutation that causes the Omicron variant is encouraging, subsequent mutations do not guarantee that the disease it causes will be less severe. As the virus continues to evolve, humans must constantly adapt by increasing their immunity through vaccination.
引用
收藏
页数:19
相关论文
共 50 条
  • [11] Neutralizing potency of COVID-19 vaccines against the SARS-CoV-2 Omicron (B.1.1.529) variant
    Lippi, Giuseppe
    Mattiuzzi, Camilla
    Henry, Brandon M.
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 1799 - 1802
  • [12] Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents
    Ma, Chengbao
    Chen, Xianying
    Mei, Fanghua
    Xiong, Qing
    Liu, Qianyun
    Dong, Lianghui
    Liu, Chen
    Zou, Wenjing
    Zhan, Faxian
    Hu, Bing
    Liu, Yingle
    Liu, Fang
    Zhou, Li
    Xu, Junqiang
    Jiang, Yongzhong
    Xu, Ke
    Cai, Kun
    Chen, Yu
    Yan, Huan
    Lan, Ke
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 567 - 572
  • [13] Adaptive immunity to SARS-CoV-2 and COVID-19
    Sette, Alessandro
    Crotty, Shane
    CELL, 2021, 184 (04) : 861 - 880
  • [14] Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era
    McCreary, Erin K.
    Kip, Kevin E.
    Collins, Kevin
    Minnier, Tami E.
    Snyder, Graham M.
    Steiner, Ashley
    Meyers, Russell
    Borneman, Tina
    Adam, Michelle
    Thurau, Lauren
    Yealy, Donald M.
    Huang, David T.
    Bariola, J. Ryan
    Schmidhofer, Mark
    Wadas, Richard J.
    Angus, Derek C.
    Kip, Paula L.
    Marroquin, Oscar C.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (10):
  • [15] Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines
    Araf, Yusha
    Akter, Fariya
    Tang, Yan-dong
    Fatemi, Rabeya
    Parvez, Md Sorwer Alam
    Zheng, Chunfu
    Hossain, Md Golzar
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 1825 - 1832
  • [16] Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
    Lee, Eunjin
    Oh, Ji Eun
    MOLECULES AND CELLS, 2021, 44 (06) : 392 - 400
  • [17] Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
    Lee, Eunjin
    Oh, Ji Eun
    MOLECULES AND CELLS, 2021, 44 (07) : 392 - 400
  • [18] Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2
    Krsak, Martin
    Harry, Brian L.
    Palmer, Brent E.
    Franco-Paredes, Carlos
    VIRAL IMMUNOLOGY, 2021, 34 (08) : 504 - 509
  • [19] Humoral and Cellular Immune Responses of COVID-19 vaccines against SARS-Cov-2 Omicron variant: a systemic review
    Chen, Zhonghao
    Zhang, Ying
    Wang, Meng
    Islam, Md Sahidul
    Liao, Ping
    Hu, Yuanjia
    Chen, Xin
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (12): : 4629 - 4641
  • [20] Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine
    Chen, Lin-Lei
    Chua, Gilbert T.
    Lu, Lu
    Chan, Brian Pui-Chun
    Wong, Joshua Sung-Chih
    Chow, Calvin Chit-Kwong
    Yu, Tak-Ching
    Leung, Agnes Sze-Yin
    Lam, Shu-Yan
    Wong, Tak-Wai
    Tsang, Hing-Wai
    Wong, Ian Chi-Kei
    Chan, Kwok-Hung
    Yuen, Kwok-Yung
    Ip, Patrick
    Kwan, Mike Yat-Wah
    To, Kelvin Kai-Wang
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 543 - 547